Health State Utilities Associated with False-Positive Cancer Screening Results.
Louis S MatzaTimothy A HowellEric T FungSam M JanesMichael SeidenAllan HackshawLincoln NadauldHayley KarnKaren C ChungPublished in: PharmacoEconomics - open (2024)
All false-positive results were associated with a disutility. Greater disutility was associated with more invasive follow-up diagnostic procedures, longer duration of uncertainty regarding the eventual diagnosis, and perceived severity of the suspected cancer type. Utility values estimated in this study would be useful for economic modeling examining the value of cancer screening procedures.